test-section



Clinical Trials

A Study of OKI-179 in Patients
With Solid Tumors

Press Releases

August 3, 2021

OnKure Expands Executive Team with the Addition of Chief Scientific Officer and Chief Development Officer

July 20, 2021

OnKure Builds its Discovery Team and Appoints Heads of Computational Drug Discovery and Pharmacology

March 3, 2021

OnKure, Inc. Raises $55 Million Series B Financing

September 21, 2020

OnKure and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Combination of OKI-179 and Binimetinib

September 24, 2019

OnKure Expands Executive Team

July 23, 2019

OnKure Executes License and Option Agreement with KDAc Therapeutics